Published in Immunity on October 01, 2000
Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med (2006) 5.35
The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol (2010) 3.97
IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med (2009) 2.78
An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol (2011) 2.69
TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol (2014) 2.62
IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med (2010) 2.36
A brief history of IL-9. J Immunol (2011) 2.27
IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med (2008) 2.19
Therapeutic targeting of Janus kinases. Immunol Rev (2008) 2.03
Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest (2002) 2.02
Th9 and allergic disease. Immunology (2009) 1.97
Cellular sources and immune functions of interleukin-9. Nat Rev Immunol (2010) 1.92
IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med (2013) 1.75
Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor. Immunity (2013) 1.75
Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med (2001) 1.74
The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity. J Exp Med (2002) 1.62
Th9 cells: differentiation and disease. Immunol Rev (2013) 1.61
Induction of Interleukin-9-Producing Mucosal Mast Cells Promotes Susceptibility to IgE-Mediated Experimental Food Allergy. Immunity (2015) 1.54
IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol (2010) 1.52
Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection. Immunity (2013) 1.32
Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J Immunol (2009) 1.28
Reversal of thymic stromal lymphopoietin-induced airway inflammation through inhibition of Th2 responses. J Immunol (2008) 1.28
IgE-mediated systemic anaphylaxis and impaired tolerance to food antigens in mice with enhanced IL-4 receptor signaling. J Allergy Clin Immunol (2010) 1.20
The development and in vivo function of T helper 9 cells. Nat Rev Immunol (2015) 1.18
Mast cell-dependent control of Giardia lamblia infections in mice. Infect Immun (2004) 1.18
Th2 cytokines and asthma. Interleukin-9 as a therapeutic target for asthma. Respir Res (2001) 1.16
Targeting the Jak/STAT pathway for immunosuppression. Ann Rheum Dis (2004) 1.16
Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25. Am J Respir Crit Care Med (2010) 1.14
Pathway analysis comparison using Crohn's disease genome wide association studies. BMC Med Genomics (2010) 1.13
Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. J Immunol (2008) 1.13
Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis. J Allergy Clin Immunol (2010) 1.13
The symphony of the ninth: the development and function of Th9 cells. Curr Opin Immunol (2012) 1.12
Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J Allergy Clin Immunol (2014) 1.12
The many lives of IL-9: a question of survival? Nat Immunol (2012) 1.11
Cytokine/anti-cytokine therapy - novel treatments for asthma? Br J Pharmacol (2011) 1.11
Role of innate lymphocytes in infection and inflammation. Front Immunol (2012) 1.08
Pathophysiological features of asthma develop in parallel in house dust mite-exposed neonatal mice. Am J Respir Cell Mol Biol (2009) 1.06
Altered regulation of Toll-like receptor responses impairs antibacterial immunity in the allergic lung. Mucosal Immunol (2012) 1.04
New drugs targeting Th2 lymphocytes in asthma. J Occup Med Toxicol (2008) 1.03
Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses. Cancer Immunol Immunother (2011) 1.03
Interleukin-9 as a T helper type 17 cytokine. Immunology (2010) 1.01
Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease. Exp Hematol (2008) 1.00
IL-4-, TGF-β-, and IL-1-dependent expansion of parasite antigen-specific Th9 cells is associated with clinical pathology in human lymphatic filariasis. J Immunol (2013) 0.99
Therapeutic administration of Budesonide ameliorates allergen-induced airway remodelling. Clin Exp Allergy (2005) 0.99
TH9 cells are required for tissue mast cell accumulation during allergic inflammation. J Allergy Clin Immunol (2015) 0.99
Mast cell progenitor trafficking and maturation. Adv Exp Med Biol (2011) 0.98
Intrathymic IL-7: the where, when, and why of IL-7 signaling during T cell development. Semin Immunol (2012) 0.97
Cutting edge: in the absence of TGF-β signaling in T cells, fewer CD103+ regulatory T cells develop, but exuberant IFN-γ production renders mice more susceptible to helminth infection. J Immunol (2012) 0.96
IL-9 contributes to immunosuppression mediated by regulatory T cells and mast cells in B-cell non-hodgkin's lymphoma. J Clin Immunol (2011) 0.94
Effects of interleukin-9 blockade on chronic airway inflammation in murine asthma models. Allergy Asthma Immunol Res (2013) 0.93
Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation. J Biol Chem (2012) 0.93
Tailored immune responses: novel effector helper T cell subsets in protective immunity. PLoS Pathog (2014) 0.92
Resolution of LPS-induced airway inflammation and goblet cell hyperplasia is independent of IL-18. Respir Res (2007) 0.91
Titanium dioxide particle-induced goblet cell hyperplasia: association with mast cells and IL-13. Respir Res (2005) 0.90
Tim1 and Tim3 are not essential for experimental allergic asthma. Clin Exp Allergy (2011) 0.88
Chronic allergen challenge induces bronchial mast cell accumulation in BALB/c but not C57BL/6 mice and is independent of IL-9. Immunogenetics (2010) 0.88
IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis. PLoS One (2012) 0.88
IL-9 and IL-13 induce mucous cell metaplasia that is reduced by IFN-gamma in a Bax-mediated pathway. Am J Respir Cell Mol Biol (2007) 0.88
Foxp3⁺ regulatory T cells delay expulsion of intestinal nematodes by suppression of IL-9-driven mast cell activation in BALB/c but not in C57BL/6 mice. PLoS Pathog (2014) 0.87
IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis. Tissue Barriers (2015) 0.86
Interleukin-10 production by myeloid-derived suppressor cells contributes to bacterial persistence during Staphylococcus aureus orthopedic biofilm infection. J Leukoc Biol (2015) 0.86
Transcriptional regulation of Th2 cell differentiation. Immunol Cell Biol (2010) 0.86
Potential effector and immunoregulatory functions of mast cells in mucosal immunity. Mucosal Immunol (2015) 0.86
Th17 cell cytokine secretion profile in host defense and autoimmunity. Inflamm Res (2011) 0.85
T regulatory cells control antigen-induced recruitment of mast cell progenitors to the lungs of C57BL/6 mice. J Immunol (2010) 0.84
IL-9-producing cells in the development of IgE-mediated food allergy. Semin Immunopathol (2016) 0.84
Interleukin-9 and T cell subsets. Cell Cycle (2009) 0.83
Distinct different expression of Th17 and Th9 cells in coxsackie virus B3-induced mice viral myocarditis. Virol J (2011) 0.82
Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges. Cancer Res (2014) 0.82
A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis. Immun Ageing (2013) 0.82
IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling. J Leukoc Biol (2011) 0.81
Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses. Immunology (2014) 0.80
Regulatory roles of mast cells in immune responses. Semin Immunopathol (2016) 0.80
γδ T cells play a protective role during infection with Nippostrongylus brasiliensis by promoting goblet cell function in the small intestine. Immunology (2011) 0.80
Dexamethasone inhibits IL-9 production by human T cells. J Inflamm (Lond) (2005) 0.79
Proteomic analysis of differently expressed proteins in a mouse model for allergic asthma. J Korean Med Sci (2005) 0.79
Characteristics of hematopoietic stem cells of umbilical cord blood. Cytotechnology (2014) 0.77
Increased differentiation of dermal mast cells in mice lacking the Mpl gene. Stem Cells Dev (2009) 0.77
Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of Asthma. PLoS One (2015) 0.76
IL-9 Inhibits Viral Replication in Coxsackievirus B3-Induced Myocarditis. Front Immunol (2016) 0.75
Leptin Enhances TH2 and ILC2 Responses in Allergic Airway Disease. J Biol Chem (2016) 0.75
IL-9 and Th9 in parasite immunity. Semin Immunopathol (2016) 0.75
Interleukin-9 (IL-9) and NPM-ALK each generate mast cell hyperplasia as single 'hit' and cooperate in producing a mastocytosis-like disease in mice. Oncotarget (2010) 0.75
IL-9 by INFERence. Immunity (2013) 0.75
MicroRNAs Involved in Asthma After Mesenchymal Stem Cells Treatment. Stem Cells Dev (2016) 0.75
IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology. Cytokine Growth Factor Rev (2017) 0.75
Influence of inhaled beclomethasone and montelukast on airway remodeling in mice. Inflammopharmacology (2012) 0.75
Phytochrome and Seed Germination. I. Temperature Dependence and Relative P(FR) Levels in the Germination of Dark-germinating Tomato Seeds. Plant Physiol (1967) 5.14
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Equity of access to health care services: theory and evidence from the UK. Soc Sci Med (2001) 4.83
Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol (2000) 4.58
Attempt at deriving a formula for setting general practitioner fundholding budgets. BMJ (1994) 4.19
The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer (2004) 4.06
Allocating resources to health authorities: development of method for small area analysis of use of inpatient services. BMJ (1994) 3.88
Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis (1992) 3.30
Agriculture. Sustainable intensification in agriculture: premises and policies. Science (2013) 3.24
Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models. Health Technol Assess (2007) 3.04
The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell (1999) 2.97
The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer (1999) 2.89
Phytochrome and Seed Germination. III. Action of Prolonged Far Red Irradiation on the Germination of Tomato and Cucumber Seeds. Plant Physiol (1967) 2.54
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest (2001) 2.49
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45
Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med (1993) 2.42
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br Med J (Clin Res Ed) (1982) 2.39
Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer (1996) 2.28
The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr Top Microbiol Immunol (2002) 2.27
The effect of brief halothane anesthesia during daily gavage on complications and body weight in rats. Contemp Top Lab Anim Sci (2001) 2.25
Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet (1992) 2.22
Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer (1998) 2.20
Cyclin D1 and prognosis in human breast cancer. Int J Cancer (1996) 2.11
Infection control for home health. Infect Control Hosp Epidemiol (1990) 2.09
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin Microbiol Rev (1998) 2.06
Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ (2008) 2.03
Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis. Clin Infect Dis (1997) 2.02
Expression of the ERBB3 gene product in breast cancer. Br J Cancer (1992) 2.01
Insights into interfacial activation from an open structure of Candida rugosa lipase. J Biol Chem (1993) 1.99
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
Effects on the right ventricle, pulmonary vasculature, and carotid bodies of the rat of exposure to, and recovery from, simulated high altitude. Thorax (1973) 1.95
Fulvine and the pulmonary circulation. Thorax (1971) 1.94
latheo encodes a subunit of the origin recognition complex and disrupts neuronal proliferation and adult olfactory memory when mutant. Neuron (1999) 1.94
Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther (2009) 1.90
Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa. Int J Tuberc Lung Dis (2002) 1.87
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism (2001) 1.87
The histopathology of 36 cases of plexogenic pulmonary arteriopathy. Histopathology (1990) 1.85
Arabidopsis consensus intron sequences. Plant Mol Biol (1996) 1.85
Aminorex and the pulmonary circulation. Thorax (1971) 1.83
Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess (2005) 1.83
Replantation. Br Med J (Clin Res Ed) (1983) 1.81
Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry (1983) 1.81
Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet (2003) 1.80
Intraoperative photodynamic therapy for malignant mesothelioma. Ann Thorac Surg (1990) 1.77
Risk factors for ovarian cancer: a case-control study. Br J Cancer (1989) 1.76
A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation (1995) 1.70
Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci U S A (2004) 1.69
Measuring the fate of plant diversity: towards a foundation for future monitoring and opportunities for urgent action. Philos Trans R Soc Lond B Biol Sci (2005) 1.68
EXPERIMENTAL NEPHRITIS IN THE FROG : I. THE ANATOMICAL EVIDENCE OF DAMAGE. J Exp Med (1930) 1.68
Human papillomavirus types 16 and 18 in carcinomas of the penis from Brazil. Int J Cancer (1986) 1.67
Statin use is associated with reduced mortality in COPD. Eur Respir J (2006) 1.66
Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology (Berl) (1991) 1.65
Increasing rate of deliberate self poisoning. BMJ (1994) 1.65
Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. BJOG (2007) 1.64
Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63
Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene (2007) 1.62
Evaluation of the home pad test in the investigation of female urinary incontinence. Br J Obstet Gynaecol (1996) 1.62
Electron microscopy of Crotalaria pulmonary hypertension. Thorax (1969) 1.61
MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology (2009) 1.61
Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. Transpl Infect Dis (2007) 1.61
Yeast chromatin. Preparation from isolated nuclei, histone composition and transcription capacity. Eur J Biochem (1973) 1.61
Technology Status Evaluation report. Colonoscopy preparations. May 2001. Gastrointest Endosc (2001) 1.61
Cloning and expression profiling of Hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun (2000) 1.59
Distribution of oxytetracycline resistance plasmids between aeromonads in hospital and aquaculture environments: implication of Tn1721 in dissemination of the tetracycline resistance determinant tet A. Appl Environ Microbiol (2000) 1.56
Electron microscopy of the plexiform lesion. Thorax (1979) 1.55
The use of dexamethasone in women with preterm premature rupture of membranes--a multicentre, double-blind, placebo-controlled, randomised trial. Dexiprom Study Group. S Afr Med J (1999) 1.53
Randomised controlled trial comparing effectiveness of touch screen system with leaflet for providing women with information on prenatal tests. BMJ (2000) 1.52
Development of a new measure of health-related quality of life for people with dementia: DEMQOL. Psychol Med (2006) 1.50
Rapid change in height and body proportions of Maya American children. Am J Hum Biol (2002) 1.47
Variations in the prevalence and intensity of microfilarial infections by age, sex, place and time in the area of the Onchocerciasis Control Programme. Trans R Soc Trop Med Hyg (1983) 1.46
Attempted suicide in social networks. Br J Prev Soc Med (1969) 1.46
Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology (1999) 1.45
Chemotherapy of advanced breast cancer: outcome and prognostic factors. Br J Cancer (1993) 1.45
Alcohol and other substance use in STD clinic patients: relationships with STDs and prevalent HIV infection. Sex Transm Dis (1994) 1.45
Traumatic hemipelvectomy. Ann Plast Surg (1991) 1.45
Age related differences in work injuries and permanent impairment: a comparison of workers' compensation claims among adolescents, young adults, and adults. Occup Environ Med (2003) 1.44
A pharmacy discharge plan for hospitalized elderly patients--a randomized controlled trial. Age Ageing (2001) 1.43
Vaginoscopic approach to outpatient hysteroscopy: a systematic review of the effect on pain. BJOG (2010) 1.42
Addition of droperidol to patient-controlled analgesia: effect on nausea and vomiting. Anaesthesia (1993) 1.41
Mitigating climate change: the role of domestic livestock. Animal (2010) 1.41
Novel human brain cDNA encoding a 34,000 Mr protein n-chimaerin, related to both the regulatory domain of protein kinase C and BCR, the product of the breakpoint cluster region gene. J Mol Biol (1990) 1.41
The predictability of bleeding by prothrombin times sensitive or insensitive to PIVKA during intensive oral anticoagulation. Thromb Res (1991) 1.40
Dose-response study of the nasal decongestant and cardiovascular effects of pseudoephedrine. Br J Clin Pharmacol (1980) 1.39
Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism (2001) 1.39
Introduction of managed care plans in a cardiac surgery unit. Contemp Nurse (1994) 1.38
[Cholesterol--now what?]. Tidsskr Nor Laegeforen (2001) 1.38
Enhancing performance in health care: a theoretical perspective on agency and the role of information. Health Econ (2000) 1.37
Mutation of putative branchpoint consensus sequences in plant introns reduces splicing efficiency. Plant J (1996) 1.36
Ultrastructure of hypoxic hypertensive pulmonary vascular disease. J Pathol (1977) 1.36
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. Br J Cancer (2009) 1.35
Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone. Eur Urol (1982) 1.35
Combined analysis of mortality in three United Kingdom nuclear industry workforces, 1946-1988. Radiat Res (1994) 1.34
Rain, winds and haze during the Huygens probe's descent to Titan's surface. Nature (2005) 1.34
Long-term follow-up of over 1000 patients with salivary gland tumours treated in a single centre. Br J Surg (1996) 1.33
Type 1 and type 2 cytokine-producing mouse CD4+ and CD8+ T cells in acute Schistosoma mansoni infection. Eur J Immunol (1998) 1.32
The Antigens Determined by the H-2 Locus: A Rhesus-Like System in the Mouse. Proc Natl Acad Sci U S A (1954) 1.32
Human brain n-chimaerin cDNA encodes a novel phorbol ester receptor. Biochem J (1990) 1.32
Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest (1999) 1.31